Ленинградский Институт Гематологии И Переливания Крови
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт элементоорганических соединений АН СССР, Ленинградский Институт Гематологии И Переливания КровиfiledCriticalИнститут элементоорганических соединений АН СССР
Priority to SU6601122112ApriorityCriticalpatent/SU263807A1/en
Application grantedgrantedCritical
Publication of SU263807A1publicationCriticalpatent/SU263807A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Description
Изобретение относитс к лечебным препаратам , примен емым дл лечени анемии и озены.The invention relates to therapeutic drugs used to treat anemia and ozena.
Известны препараты подобного рода, однако применение их св зано с побочными реакци ми .Preparations of this kind are known, but their use is associated with side reactions.
В качестве средства дл лечени анемии и озены предлагаетс примен ть натриевую соль О-карбоксибензоилферроцена {эритростимулина ), что обеспечивает отсутствие побочных реакций .As an agent for treating anemia and ozena, it is proposed to use the sodium salt of O-carboxybenzoylferrocene {erythrostimulin), which ensures the absence of side reactions.
Препарат примен етс в форме таблеток темно-оранжевого цвета с Ьодержанием 0,3 гThe drug is applied in the form of dark orange tablets with a content of 0.3 g
натриевой соли О-карбоксибензоилферроцена, метод получени которой известен по авт. св. № 179309.sodium salt of O-carboxybenzoyl ferrocene, the method of preparation of which is known by the author. St. No. 179309.
Claims (1)
Формула изобретени Invention FormulaПрименение натриевой соли О-карбоксибензоилферроцена (эритростимулина) в качестве Use of O-carboxybenzoylferrocene (erythrostimulin) sodium salt asto средства дл лечени анемии и озены.to treat anemia and ozena.
METHOD OF PREPARATION OF A MEDICINAL PRODUCT WITH BETA-RENERGIC BLOCKING ACTION THAT A 1-PHENOXY-2-HYDROXY-3-ALKYLAMINOPROPAND DERIVATIVE AND / OR A PHARMACEUTICAL ACCEPTABLE SODA SUGGESTED SODA SUGGESTED SOA PREPARATION OF THESE DERIVATIVES AND THEIR ACID ADDITIONAL SALTS.
PROCESS FOR THE PREPARATION OF A DRUG THAT OF CERTAIN 1-quinolyl-2-ALKYLAMINOETHANOLDERIVATEN AND / OR acid addition salts CONTAINS AND USING THIS PROCESS OBTAINED SHAPED DRUGS, AND METHOD FOR PRODUCING SUCH MEDICINAL derivatives and their acid addition salts .
PROCESS FOR THE PREPARATION OF ANALGETICALLY ACTIVE HEXAHYDRO-1H-AZEPINE DERIVATIVES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON HEXAHYDRO-1H-AZEPINE DERIVATIVES AND THEIR DUE-IN-ART.
PROCESS FOR THE PREPARATION OF NEW COMPOUNDS, PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND MEDICINAL PRODUCTS OBTAINED BY THAT PROCESS.
NEW 1-DESOXY-RIBOFURANURONIC ACID DERIVATIVES AND THERAPEUTIC PREPARATIONS CONTAINING ONE OR MORE OF THESE COMPOUNDS, AS WELL AS METHODS OF PREPARATION FOR THESE COMPOUNDS AND PREPARATIONS.
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS IN WHICH ONE PUTS 11-ALKOXY-3-KETOSTEROIDS WITH AN OXYGEN FUNCTION IN THE 17-PLACE IN MEDICAL USE FORM OF ADMINISTRATION, THE PREPARED MEDICINAL PRODUCTS, AS PREPARED MEDICINAL PRODUCTS, AS PREPARED PREPARATIONS.
PROCESS FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING AN ACID ADDITION SALT OF AN OXADIAZOLE DERIVATIVE, THE THERAPEUTIC PREPARATIONS OBTAINED THROUGH THE USE OF THIS PROCESS AND PROCESS FOR THE PROCESSED PROCESS.